Latest 10-Q quarterly reports

Treace Medical Concepts reported a 4.2% revenue decrease in Q2 2026 compared to the prior year, alongside an increased net loss and ongoing litigation.

Mobility Global Inc. reported its second-quarter 2026 financial results following its separation from S&P Global, showing revenue growth and solid Adjusted EBITDA, alongside significant debt issuance.

Somnigroup International's Q2 2026 results show a 3.0% decrease in net sales to $1.82 billion, but operating income rose 12.1% to $201.7 million, driven by improved gross margins and cost management.

Kiora Pharmaceuticals, Inc. (KPRX) filed its Form 10-Q for the quarter ended June 30, 2026, detailing progress in its clinical-stage retinal disease programs, strategic collaborations, and financial position.

DraftKings Inc. reported a net loss of $67.6 million for the second quarter of 2026, a significant decrease from a net income of $157.9 million in the prior year, with revenue also declining.

ANI Pharmaceuticals announced a 25.9% increase in net revenues for the second quarter of 2026, driven by significant growth in its Rare Disease and Brands segment.

Starz Entertainment Corp. disclosed a substantial net loss of $189.4 million for the second quarter of 2026, alongside a notable decrease in total revenue.

ARKO Corp. reported increased fuel revenue driven by higher prices, but experienced a decline in net income and merchandise revenue in its Q2 2026 filing, while also detailing strategic transformations and market challenges.

Nathans Famous, Inc. announced its first quarter fiscal year 2027 results, showing a 15% increase in total revenues driven by pricing actions and licensing growth, while navigating inflationary pressures and a pending merger with Smithfield Foods.

Boundless Bio announces a merger with Serapha Bio, Inc., shifting focus to Serapha's Alpha-1 Antitrypsin Deficiency therapy and discontinuing its own ecDTx programs, while reporting increased net loss and significant workforce reduction.

Canopy Growth Corporation's Q1 2027 filing shows a 13% increase in net revenue to $81.2 million, but a net loss of $14.6 million, with significant cash used in operations.

HA Sustainable Infrastructure Capital, Inc. (HASI) reported a significant increase in total revenue for the three months ended June 30, 2026, driven by higher interest and rental income, and gains on asset sales.

Trulieve Cannabis Corp. filed its Q2 2026 Form 10-Q, detailing a significant net loss driven by a $403.3 million loss on deconsolidation of Harvest, alongside revenue declines and operational adjustments.

Earth Science Tech, Inc. announced its Q2 2026 results, showcasing a 3% revenue increase and a significant rise in net income, driven by operational efficiencies and strategic investments.

Ernexa Therapeutics reported increased R&D expenses and a net loss for the six months ended June 30, 2026, while also addressing Nasdaq listing requirements and advancing its ERNA-101 program.

Pacific Biosciences of California, Inc. reported a 2% decrease in total revenue for Q2 2026 compared to the prior year, alongside a significant operating loss, while implementing restructuring measures and leadership changes.

Savers Value Village announced a 7.4% increase in net sales to $448.2 million for the thirteen weeks ended July 4, 2026, driven by store growth and comparable store sales.

Granite Ridge Resources' Q2 2026 filing shows a significant increase in oil revenues driven by higher prices and production, alongside a net loss for the six-month period due to increased expenses and derivative impacts.

Optimum Communications, Inc. reported a net loss and highlighted substantial debt maturities in its latest SEC filing, raising significant concerns about its ability to continue as a going concern.

Income Opportunity Realty Investors, Inc. reported stable financial results for the second quarter of 2026, with net income of $705,000, primarily driven by interest income from related parties.

Dorchester Minerals L.P. announced a substantial increase in revenue and net income for the second quarter of 2026, driven by higher commodity prices and increased production volumes.

Astrotech Corporation's amended Q3 2026 filing reveals a substantial revenue decrease and an increased net loss, highlighting ongoing financial challenges despite technological progress.

KKR & Co. Inc. announced its Q2 2026 financial results, showcasing significant growth in Assets Under Management (AUM) and improved profitability driven by strong performance in its Asset Management and Insurance segments.

Excelerate Energy's Q2 2026 results show significant revenue and net income increases, driven by the Jamaica acquisition and strong LNG market performance.

Beyond Meat reported a decline in net revenues for the second quarter of 2026, alongside continued operating losses, while also detailing a strategic repositioning and new product introductions.

PAR Technology Corporation announced its second quarter 2026 financial results, showing an 18.7% increase in total revenue to $133.4 million, driven by subscription and hardware segments, though the company reported a net loss.

iRhythm Holdings, Inc. announced a 20% increase in revenue for the second quarter of 2026, driven by higher patient service volumes, while also addressing a $45 million securities litigation settlement.

Amneal Pharmaceuticals, Inc. announced a significant increase in net revenue and operating income for the second quarter of 2026, driven by growth across its key segments.

Chesapeake Utilities Corporation announced solid financial and operational results for the second quarter of 2026, driven by growth in regulated energy segments and strategic infrastructure investments.

SkinHealth Systems Inc. reported a decline in net sales for the second quarter of 2026, alongside increased interest expenses and significant legal matters, though gross margin improved.